UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047841
Receipt number R000054543
Scientific Title Prognosis of lung metastases of colorectal cancer
Date of disclosure of the study information 2022/05/24
Last modified on 2023/05/25 10:28:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prognosis of lung metastases of colorectal cancer

Acronym

Prognosis of lung metastases of colorectal cancer

Scientific Title

Prognosis of lung metastases of colorectal cancer

Scientific Title:Acronym

Prognosis of lung metastases of colorectal cancer

Region

Japan


Condition

Condition

lung metastases of colorectal cancer

Classification by specialty

Surgery in general Hepato-biliary-pancreatic surgery Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify prognostic factor of lung metastases of colorectal cancer

Basic objectives2

Others

Basic objectives -Others

To survey the recurrence after resection for lung metastases of colorectal cancer

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Overall survival of lung metastases of colorectal cancer

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who underwent surgical treatment for lung metastases of colorectal cancer

Key exclusion criteria

None

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Shintaro
Middle name
Last name Hashimoto

Organization

Nagasaki University Hospital

Division name

Surgical oncology

Zip code

8528511

Address

1-7-1, Sakamoto, Nagasaki City, Nagasaki, Japan

TEL

0958197304

Email

s.hashi12@outlook.jp


Public contact

Name of contact person

1st name Shintaro
Middle name
Last name Hashimoto

Organization

Nagasaki University Hospital

Division name

Surgical oncology

Zip code

8528511

Address

1-7-1, Sakamoto, Nagasaki City, Nagasaki, Japan

TEL

0958197304

Homepage URL


Email

s.hashi12@outlook.jp


Sponsor or person

Institute

Nagasaki University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki University Hospital

Address

1-7-1, Sakamoto, Nagasaki City, Nagasaki, Japan

Tel

0958197304

Email

s.hashi12@outlook.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 05 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

On multivariate analysis, lymph node metastasis of the primary resection site (HR 1.683, 95%CI 1.003-2.824, p=0.049) was an independent predictor for poor RFS, and history of extra-PM (e-PM) (HR 2.328, 95%CI 1.139-4.761, p=0.021) was an independent predictor for poor OS.

Results date posted

2023 Year 05 Month 25 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 05 Month 11 Day

Date of IRB


Anticipated trial start date

2022 Year 05 Month 31 Day

Last follow-up date

2023 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We survey the clinical and surgical record of the patients who experienced surgical treatment for lung metastases of colorectal cancer.


Management information

Registered date

2022 Year 05 Month 24 Day

Last modified on

2023 Year 05 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054543


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name